Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Because of the ever-expanding use of GLP-1 receptor agonists, the availability of an oral agent within this therapeutic class has the potential to further increase GLP-1 receptor agonist use and provide an alternative route of administration for patients unable or unwilling to take SC injections
they do not create a thermodynamic deficit on their own
*sunset yellow fcf: may have an adverse effect on activity and attention in children
Understanding these potential nutritional impacts is important for patients and healthcare providers to implement appropriate dietary strategies that support safe and sustainable weight loss while on Zepbound therapy
These small benefits can add up over time
Current Obesity Reports
